Tag:
spinoff
Latest Headlines
Latest Headlines
Big Pharma buybacks, spinoffs cater to investors
How can a drugmaker please shareholders when R&D productivity is, to put it politely, in the tank? Point to shiny objects in the opposite direction. If pharma companies weren't buying back shares
Should Big Pharma spin off to goose shares?
Should Big Pharma shrink itself? We've seen drugmakers revamp themselves to mimic smaller biotech shops, hoping that splitting into teams will boost innovation and accountability. We've heard
BMS plots $6.5B Mead spinoff
Last week we reported that a debt-refinancing at Mead Johnson yielded $1.75 billion in cash for parent Bristol-Myers Squibb. But that's just a fraction of the some $6.5 billion Bristol could net from
Bitter medicine for Big Pharma
In the latter part of the 20th century, the conventional wisdom in the drug industry was simple: bigger is
Pfizer plots spinoff of Japanese R&D
Saved by the spinoff. Pfizer is looking to set up its Japanese R&D operation, previously slated for shutdown, as an independent company--with the help of a few investors, of course. The company
